HAMILL JOHN P. (SrVP/CFO/Prin Fin & Acct Ofcr) purchased 22.0% of their position (5K shares) of APREA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.8K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/11/2025ACC: 0001104659-25-120155
Officer· SrVP/CFO/Prin Fin & Acct Ofcr
Since Jan 2026
+10K
Net shares
Net buyer
$5.8K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.17
Trade value
$5.83K
% of position
22.0%
12/10/2025
22.73K→27.73K
Total
Net shares
+5K
Net value
$5.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2025 | P · Purchase | +5K | $1.17 | $5.83K | 22.0% | 22.73K | 27.73K |
| Total | +5K | $5.83K | ||||||
Derivative Transactions1
Common Warrant
Direct
Converts to
Common Stock
5K shares
Shares
+5K
Strike price
1.04
Held after
5K
Exercisable
—
12/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Warrant Direct | Common Stock5K shares | 12/10/2025 | P · Purchase | +5K | 1.04 | — | 5K |